The Value of Lymph Node Dissection in Patients With Node-Positive Upper Urinary Tract Urothelial Cancer: A Retrospective Cohort Study

被引:3
|
作者
Xia, Hao-ran [1 ,4 ]
Li, Shu-guang [2 ]
Zhai, Xing-quan [2 ]
Liu, Min [1 ,4 ]
Guo, Xiao-xiao [3 ]
Wang, Jian-ye [1 ,4 ]
机构
[1] Beijing Hosp, Natl Ctr Gerontol, Dept Urol, Beijing, Peoples R China
[2] Zoucheng Peoples Hosp, Dept Urol, Zoucheng, Peoples R China
[3] Capital Med Univ, Beijing Friendship Hosp, Dept Urol, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Inst Geriatr Med, Beijing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
upper urinary tract urothelial cancer; lymphadenectomy; removed lymph nodes; positive lymph nodes; positive lymph node density; RADICAL NEPHROURETERECTOMY; CARCINOMA; LYMPHADENECTOMY; IMPACT; SURVIVAL;
D O I
10.3389/fonc.2022.889144
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe value of lymphadenectomy during radical nephroureterectomy (RNU) remains unclear. This study aimed to determine the effects of the removed lymph node (RLN) counts, positive lymph node (pLN) counts, and pLN density (pLND) on survival outcomes in patients with node-positive upper urinary tract urothelial cancer (UTUC). MethodsA total of 306 patients with node-positive UTUC in the Surveillance, Epidemiology, and End Results database between 2004 and 2016 were identified. Multivariable Cox regression analyses were used to evaluate the effect of RLN counts, pLN counts, and pLND on survival outcomes. The maximally selected rank statistics were used to determine the most informative cutoff value for pLND on survival outcomes. ResultsThe RLN counts or pLN counts were not associated with survival outcomes, whereas higher pLND was associated with lower cancer-specific survival (CSS) and overall survival (OS) [hazard ratio (HR) 1.75, P = 0.014 and HR 1.62, P = 0.036, respectively]. The most informative cutoff value for pLND in relation to survival was 27%. Patients with pLND >= 27% had worse 5-year survival rates than those with pLND <27% (52.9% vs. 75.9% for CSS and 18.7% vs. 34.2% for OS, each P < 0.05). Furthermore, the multivariable Cox regression model with pLND could predict 5-year CSS (AUC 0.732 vs. 0.647) or OS (AUC 0.704 vs. 0.621) more accurately than the model without pLND. ConclusionsFor patients with node-positive UTUC, more lymph nodes removed do not offer a better therapeutic effect. However, pLND provides additional prognostic value.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Evaluation of regional lymph node dissection in patients with upper urinary tract urothelial cancer
    Secin, Fernando P.
    Koppie, Theresa M.
    Martinez Salamanca, Juan I.
    Bokhari, Shahid
    Raj, Ganesh V.
    Olgac, Semra
    Serio, Angel
    Vickers, Andrew
    Bochner, Bernard H.
    INTERNATIONAL JOURNAL OF UROLOGY, 2007, 14 (01) : 26 - 32
  • [2] Lower axillary dissection in patients with sentinel lymph node-positive breast cancer: A retrospective cohort study
    Yamaguchi, Ai
    Kataoka, Yuki
    Taji, Tomoe
    Suwa, Hirofumi
    ASIAN JOURNAL OF SURGERY, 2020, 43 (11) : 1099 - 1100
  • [3] LAPAROSCOPIC LYMPH NODE DISSECTION FOR UPPER TRACT UROTHELIAL CANCER
    Kawauchi, Akihiro
    Naya, Yoshio
    Hongo, Fumiya
    Soh, Jintetsu
    Naitoh, Yasuyuki
    Nakamura, Terukazu
    Kamoi, Kazumi
    Okihara, Koji
    Miki, Tsuneharu
    JOURNAL OF ENDOUROLOGY, 2012, 26 : A166 - A167
  • [4] The Association between Lymph Node Dissection and Survival in Lymph Node-Negative Upper Urinary Tract Urothelial Cancer
    Slusarczyk, Aleksander
    Zapala, Piotr
    Piecha, Tomasz
    Rajwa, Pawel
    Moschini, Marco
    Radziszewski, Piotr
    CANCERS, 2023, 15 (18)
  • [5] The role of lymph node dissection in the management of urothelial carcinoma of the upper urinary tract
    Kondo, Tsunenori
    Tanabe, Kazunari
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2011, 16 (03) : 170 - 178
  • [6] The role of lymph node dissection in the management of urothelial carcinoma of the upper urinary tract
    Tsunenori Kondo
    Kazunari Tanabe
    International Journal of Clinical Oncology, 2011, 16 : 170 - 178
  • [7] The role of adjuvant chemotherapy for lymph node-positive upper tract urothelial carcinoma following radical nephroureterectomy: a retrospective study
    Lucca, Ilaria
    Kassouf, Wassim
    Kapoor, Anil
    Fairey, Adrian
    Rendon, Ricardo A.
    Izawa, Jonathan I.
    Black, Peter C.
    Fajkovic, Harun
    Seitz, Christian
    Remzi, Mesut
    Nyirady, Peter
    Roupret, Morgan
    Margulis, Vitaly
    Lotan, Yair
    de Martino, Michela
    Hofbauer, Sebastian L.
    Karakiewicz, Pierre I.
    Briganti, Alberto
    Novara, Giacomo
    Shariat, Shahrokh F.
    Klatte, Tobias
    BJU INTERNATIONAL, 2015, 116 (01) : 72 - 78
  • [8] Lymph Node Dissection in Upper Tract Urothelial Cancer: Ready for Prime Time?
    Tissot, Gabrielle
    Xylinas, Evanguelos
    JOURNAL OF UROLOGY, 2023, 209 (03): : 462 - 463
  • [9] Avoidance of axillary lymph node dissection in selected patients with node-positive breast cancer
    Noguchi, M.
    EJSO, 2008, 34 (02): : 129 - 134
  • [10] A Critical Appraisal of the Value of Lymph Node Dissection at Nephroureterectomy for Upper Tract Urothelial Carcinoma
    Lughezzani, Giovanni
    Jeldres, Claudio
    Isbarn, Hendrik
    Shariat, Shahrokh F.
    Sun, Maxine
    Pharand, Daniel
    Widmer, Hugues
    Arjane, Philippe
    Graefen, Markus
    Montorsi, Francesco
    Perrotte, Paul
    Karakiewicz, Pierre I.
    UROLOGY, 2010, 75 (01) : 118 - 124